Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma Of Esophagus

Explore clinical trials studying Adenocarcinoma Of Esophagus. Study availability and eligibility vary by location and protocol.

254 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma Of Esophagus trial results

Completed

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

NCT00052910

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 535 locations
View Trial Details
Completed

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

NCT00047112

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Hopital Universitaire Erasme Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • Universiteit Gent Ghent, Belgium
View all 73 locations
View Trial Details
Completed

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

NCT01498289

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +12 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 508 locations
View Trial Details
Completed

S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT00096031

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Eden Medical Center Castro Valley, California, United States
View all 152 locations
View Trial Details
Completed

Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction

NCT00891878

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +9 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Illinois CancerCare - Bloomington Bloomington, Illinois, United States
View all 182 locations
View Trial Details

Related conditions